Neuromeka Statistics

Total Valuation

Neuromeka has a market cap or net worth of KRW 247.98 billion. The enterprise value is 283.85 billion.

Market Cap	247.98B
Enterprise Value	283.85B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Neuromeka has 11.35 million shares outstanding. The number of shares has increased by 1.54% in one year.

Current Share Class	11.35M
Shares Outstanding	11.35M
Shares Change (YoY)	+1.54%
Shares Change (QoQ)	+2.75%
Owned by Insiders (%)	20.27%
Owned by Institutions (%)	0.33%
Float	9.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.00
PB Ratio	10.78
P/TBV Ratio	10.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-15.47
EV / Sales	11.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.00

Financial Position

The company has a current ratio of 0.91, with a Debt / Equity ratio of 2.19.

Current Ratio	0.91
Quick Ratio	0.57
Debt / Equity	2.19
Debt / EBITDA	n/a
Debt / FCF	-1.24
Interest Coverage	-3.56

Financial Efficiency

Return on equity (ROE) is -88.36% and return on invested capital (ROIC) is -17.02%.

Return on Equity (ROE)	-88.36%
Return on Assets (ROA)	-12.25%
Return on Invested Capital (ROIC)	-17.02%
Return on Capital Employed (ROCE)	-37.29%
Revenue Per Employee	174.67M
Profits Per Employee	-129.21M
Employee Count	142
Asset Turnover	0.27
Inventory Turnover	3.33

Taxes

In the past 12 months, Neuromeka has paid 26.62 million in taxes.

Income Tax	26.62M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.35% in the last 52 weeks. The beta is 0.93, so Neuromeka's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	-1.35%
50-Day Moving Average	23,210.00
200-Day Moving Average	25,379.70
Relative Strength Index (RSI)	37.35
Average Volume (20 Days)	30,562

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Neuromeka had revenue of KRW 24.80 billion and -18.35 billion in losses. Loss per share was -1,726.45.

Revenue	24.80B
Gross Profit	3.83B
Operating Income	-18.18B
Pretax Income	-18.32B
Net Income	-18.35B
EBITDA	-15.75B
EBIT	-18.18B
Loss Per Share	-1,726.45

Full Income Statement

Balance Sheet

The company has 14.52 billion in cash and 50.39 billion in debt, giving a net cash position of -35.87 billion or -3,160.93 per share.

Cash & Cash Equivalents	14.52B
Total Debt	50.39B
Net Cash	-35.87B
Net Cash Per Share	-3,160.93
Equity (Book Value)	23.01B
Book Value Per Share	2,029.37
Working Capital	-4.21B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -26.79 billion and capital expenditures -13.78 billion, giving a free cash flow of -40.56 billion.

Operating Cash Flow	-26.79B
Capital Expenditures	-13.78B
Free Cash Flow	-40.56B
FCF Per Share	-3,574.14

Full Cash Flow Statement

Margins

Gross margin is 15.44%, with operating and profit margins of -73.31% and -73.97%.

Gross Margin	15.44%
Operating Margin	-73.31%
Pretax Margin	-73.87%
Profit Margin	-73.97%
EBITDA Margin	-63.52%
EBIT Margin	-73.31%
FCF Margin	n/a

Dividends & Yields

Neuromeka does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.54%
Shareholder Yield	n/a
Earnings Yield	-7.40%
FCF Yield	-16.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Neuromeka has an Altman Z-Score of 1.28 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.28
Piotroski F-Score	2